Everolimus and Squamous cell carcinoma of skin - a phase IV clinical study of FDA data

Summary:

Squamous cell carcinoma of skin is reported as a side effect among people who take Everolimus (everolimus), especially for people who are male, 50-59 old, have been taking the drug for 1 - 2 years also take Tacrolimus, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Squamous cell carcinoma of skin when taking Everolimus. It is created by eHealthMe based on reports of 16,218 people who have side effects when taking Everolimus from the FDA, and is updated regularly.

What is Everolimus?

Everolimus has active ingredients of everolimus. eHealthMe is studying from 16,228 Everolimus users. Check the latest studies of Everolimus.

What is Squamous cell carcinoma of skin?

Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin) is found to be associated with 583 drugs and 651 conditions by eHealthMe. Check the latest studies of Squamous cell carcinoma of skin.

On Jul, 08, 2026

16,218 people reported to have side effects when taking Everolimus.
Among them, 84 people (0.52%) have Squamous cell carcinoma of skin.

Could Everolimus cause Squamous cell carcinoma of skin?

Among these 84 people:

How long have people been on Everolimus when they have Squamous cell carcinoma of skin? *

What is the gender of people who have Squamous cell carcinoma of skin when taking Everolimus? *

female: 8.64 %
male: 91.36 %

What is the age of people who have Squamous cell carcinoma of skin when taking Everolimus? *

What are other drugs people take besides Everolimus? *

Tacrolimus: 22 people, 26.19%
Voriconazole: 15 people, 17.86%
Prednisolone: 13 people, 15.48%
Mycophenolate Mofetil: 13 people, 15.48%
Cyclosporine: 11 people, 13.10%
Azathioprine: 8 people, 9.52%
Atorvastatin Calcium: 6 people, 7.14%
Valacyclovir Hydrochloride: 5 people, 5.95%
Sirolimus: 5 people, 5.95%
Ganciclovir: 5 people, 5.95%

What are other side effects people have besides Squamous cell carcinoma of skin? *

Bowen's Disease (early stage of skin cancer): 46 people, 54.76%
Actinic Keratosis (skin disease due to sun exposure): 30 people, 35.71%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 30 people, 35.71%
Metastases To Salivary Gland (cancer spreads to salivary gland): 5 people, 5.95%
Skin Cancer: 3 people, 3.57%
Second Primary Malignancy (after getting cure a cancer, a new cancer development): 3 people, 3.57%
Rashes (redness): 3 people, 3.57%
Cellulitis (infection under the skin): 3 people, 3.57%
Urinary Tract Infection Pseudomonal: 2 people, 2.38%
The Flu (the flu is caused by an influenza virus): 2 people, 2.38%

What are the existing conditions these people have? *

Immunodeficiency Disorders: 15 people, 17.86%
Photosensitivity Reaction: 10 people, 11.90%
High Blood Pressure: 4 people, 4.76%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 3.57%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 3.57%
Pancreatic Neuroendocrine Tumor: 2 people, 2.38%
Insulinoma (tumour of the pancreas that is derived from beta cells and secretes insulin): 1 person, 1.19%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 1.19%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 1 person, 1.19%

* Approximation only. Some reports may have incomplete information.

Do you take Everolimus and have Squamous cell carcinoma of skin?

- Check whether Squamous cell carcinoma of skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Everolimus:

Everolimus (16,228 reports)

Browse all side effects of Everolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Squamous cell carcinoma of skin:

Squamous cell carcinoma of skin (583 drugs)

Browse all the conditions that are associated with Squamous cell carcinoma of skin:

Squamous cell carcinoma of skin (651 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on everolimus (the active ingredients of Everolimus) and Everolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.